2D QSAR Studies on Series of Human Beta-secretase (BACE-1) Inhibitors

ISSN: 1875-6638 (Online)
ISSN: 1573-4064 (Print)

Volume 13, 8 Issues, 2017

Download PDF Flyer

Medicinal Chemistry

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Honorary Life Fellow
Kings College
University of Cambridge
Email: mc@benthamscience.org

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 1.458
5 - Year: 1.423

2D QSAR Studies on Series of Human Beta-secretase (BACE-1) Inhibitors

Medicinal Chemistry, 10(2): 162-173.

Author(s): Daniela Santos Cruz and Marcelo Santos Castilho.

Affiliation: Laboratorio de Bioinformatica e Modelagem Molecular, Faculdade de Farmacia, Universidade Federal da Bahia, CEP 40170-115, Brazil.


β -secretase (BACE-1) plays a pivotal role in the β-Amyloid plaques formation, which is responsible for progressive cognitive and memory loss commonly found in Alzheimer disease patients. As a consequence, it has been considered as a good target for drug development efforts. Early work focused on the synthesis of peptidomimetics, but poor pharmacokinetics profile prevented advancing lead compounds to clinical trials. As an alternative, aminoimidazoles, aminohydantoins and aminopyridines derivatives that inhibit BACE-1 were designed. Herein we report statistically sound descriptor- based (r2 = 0.87, q2 = 0.85, 6 PCs) and fragment-based (r2 = 0.91, q2 = 0.84, 6 PCs) QSAR models, that show high predictive ability (r2 pred = 0.84, averaged r2 m=0.78) and underscore polar interactions that are important for BACE-1 inhibition.


Alzheimer, β -Amyloid, Beta-secretase (BACE-1), 2D-QSAR, Hologram QSAR.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 10
Issue Number: 2
First Page: 162
Last Page: 173
Page Count: 12
DOI: 10.2174/15734064113099990002
Price: $58

Related Journals

Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science